Medications for Itching in ESRD
Gabapentin 100-300 mg administered after each hemodialysis session (three times weekly) is the most effective first-line medication for uremic pruritus in ESRD patients, with the strongest evidence base and greatest reduction in itch scores. 1, 2, 3
First-Line Pharmacologic Treatment
Gabapentin (Preferred)
- Gabapentin demonstrates the greatest reduction in itch scores among all studied interventions for uremic pruritus, with high-certainty evidence showing a 4.95 cm reduction on the 10 cm Visual Analogue Scale compared to placebo. 3
- Dosing is dramatically lower than non-ESRD populations: 100-300 mg after each dialysis session (three times weekly), not daily dosing. 1, 2
- Pregabalin is an alternative gabapentinoid with similar efficacy. 3
Kappa-Opioid Agonists (Alternative First-Line)
- Nalfurafine reduces itch with high-certainty evidence, showing a 1.05 cm reduction on VAS compared to placebo, though this effect is more modest than gabapentin. 3, 4
- Available in Japan and some other countries for uremic pruritus. 4
Topical Therapy (Adjunctive or Localized Itch)
Capsaicin 0.025% Cream
- Apply four times daily to affected areas, with 14 of 17 patients in randomized trials reporting marked relief and 5 achieving complete remission. 1, 2
- Works by depleting substance P and other neuropeptides in peripheral sensory neurons. 1
Emollients
- Apply regularly to all patients, as xerosis (dry skin) affects 54-69% of dialysis patients and lowers the threshold for itch. 1, 5
- Should be used as baseline therapy regardless of other interventions. 6, 7
Second-Line Options
Oral Medications with Moderate Evidence
- Montelukast showed itch reduction in small studies. 3
- Turmeric demonstrated benefit but requires further investigation. 3
- Zinc sulfate reduced itch scores in limited trials. 3
Phototherapy
- Broad-band UVB phototherapy is effective for many patients and can be used as an escalation option if gabapentin fails after 2-4 weeks. 1, 2, 6, 7
Medications to AVOID
Antihistamines (Ineffective for Uremic Pruritus)
- Cetirizine and other antihistamines are specifically ineffective for uremic pruritus despite efficacy in other conditions. 1, 2
- Ondansetron showed little or no effect on itch scores (0.38 cm reduction on VAS, not clinically significant) with high-certainty evidence. 3
- First-generation sedating antihistamines (diphenhydramine, hydroxyzine) should be avoided except in palliative care due to increased risk of falls, sedation, and potential dementia risk. 2
Other Ineffective Topicals
- Calamine lotion has no literature supporting its use for uremic pruritus. 1
- Crotamiton cream has been shown ineffective compared to vehicle control. 1
Essential Concurrent Optimization
Dialysis Adequacy
- Ensure target Kt/V of approximately 1.6, as pruritus is more common in underdialyzed patients and higher dialysis efficacy reduces prevalence. 1, 2, 8
Metabolic Parameters
- Normalize calcium-phosphate balance to accepted ranges. 1, 2, 5
- Control parathyroid hormone levels. 1, 2, 5
- Correct anemia with erythropoietin if present. 1, 2
Treatment Algorithm
- Start with emollients for all patients plus optimize dialysis adequacy and metabolic parameters. 1, 5
- Add gabapentin 100-300 mg after each dialysis session as first-line systemic therapy. 1, 2, 3
- For localized itch, add capsaicin 0.025% cream four times daily to affected areas. 1, 2
- If inadequate response after 2-4 weeks, consider broad-band UVB phototherapy or switch to nalfurafine if available. 1, 3, 6
- For refractory cases, consider μ-opioid receptor antagonists (naltrexone) or κ-opioid receptor agonists as experimental options. 6
Critical Pitfalls
- Do not prescribe antihistamines expecting benefit for uremic pruritus—they are ineffective for this specific indication. 1, 2, 3
- Do not use standard gabapentin dosing; ESRD patients require dramatically reduced doses (100-300 mg three times weekly, not daily). 1, 2
- Administer all oral medications after hemodialysis sessions to avoid premature drug removal. 2
- If localized itch spreads to become generalized, this indicates broader uremic pruritus requiring systemic therapy escalation. 1